CD40 Inhibition with CFZ533-A New, Fully Human, Non-Depleting, Fc Silent mAB - Improves Renal Allograft Function While Demonstrating Comparable Efficacy vs. Tacrolimus in De-Novo CNI-Free Kidney Transplant Recipients
Autor: | B Haraldsson, Oliver Witzke, M. van den Hoogen, D Leeser, J Rush, Shamkant Mulgaonkar, Diane M. Cibrik, J Pratschke, U Laessing, A Patel, Bjoern Nashan, Claudia Sommerer, Stefan P Berger, Rita R. Alloway, A D van Zuilen, H. Tedesco, Alexander C. Wiseman |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Transplantation medicine.medical_specialty CD40 biology business.industry medicine.drug_class Urology Monoclonal antibody Kidney transplant Tacrolimus 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Renal allograft biology.protein Medicine business Function (biology) |
Zdroj: | Transplantation. 102:366-366 |
ISSN: | 1534-6080 0041-1337 |
Databáze: | OpenAIRE |
Externí odkaz: |